Advances in Contraception

, Volume 3, Issue 2, pp 125–131 | Cite as

The prophylactic properties of the Today® sponge and other spermicide containing contraceptives

  • K. L. Berger
  • K. Remington


Public Health Prophylactic Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Singh, B. and Cutler, J. C. (1982). Demonstration of a spirocheticidal effect by chemical contraceptives onTreponema pallidum. Pan American Health Organization Bulletin,16,(1)Google Scholar
  2. 2.
    Singh, B., Cutler, J. C. and Utidjian, H. M. D. (1972). Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception;in vitro effect of vaginal contraceptive and selected vaginal preparations ofCandida albicans andTrichomonas vaginalis. Contraception,5,(95)Google Scholar
  3. 3.
    BenesS. and McCormackW. M. (1985). Inhibition of growth ofChlamydia trachomatis by Nonoxynol-9in vitro.Antimicrob. Agents Chemother.,27(5), 724–726Google Scholar
  4. 4.
    KellyJ. P., ReynoldsR. B., StagnoS., LouvW. C. and AlexanderW. J. (1985).In vitro activity of the spermicide nonoxynol-9 againstChlamydia trachomatis.Antimicrob. Agents Chemother.,27, 760–762Google Scholar
  5. 5.
    SinghB., PosticB. and CutlerJ. C. (1976). Virucidal effect of certain chemical contraceptives on type 2 herpes virus.Am. J. Obstet. Gynecol.,126, 422–425Google Scholar
  6. 6.
    JickH., HannanM. T., StergachisA., HeldrichF., PereraD. R. and RothmanK. J. (1982). Vaginal spermicides and gonorrhea.J. Am. Med. Assoc.,248, 1619–1621Google Scholar
  7. 7.
    Austin, H., Louv, W. C. and Alexander, W. J. (1984). A case-control study of spermicides and gonorrhea.J. Am. Med. Assoc.,251(21)Google Scholar
  8. 8.
    Kelaghan, J., Rubin, G. L., Ory, H. W. and Layde, P. M. (1982). Barrier-method contraceptives and pelvic inflammatory disease.J. Am. Med. Assoc.,248(2)Google Scholar
  9. 9.
    Rendon, A., Covarrubias, L. J., McCarney, K. E., Marion-Landais, G. T. and Luna del Villar, J. (1980). A controlled, comparative study of phenylmercuric acetate, Nonoxynol-9 and placebo vaginal suppositories as prophylactic agents against gonorrhea.Curr. Ther. Res.,27(6), Section 1Google Scholar
  10. 10.
    Singh, B. and Cutler, J. C. (1979). Vaginal contraceptives for prophylaxis against sexually transmissible diseases. InVaginal Contraception: New Developments, Zatuchni, G. I., Sobrero, A. J., Speidel, J. J. and Sciarra, J. J., eds., Chapter 17, pp. 175–185Google Scholar
  11. 11.
    Rosenberg, M. J. Feldblum, P. J., Rojanapithayakorn, W. and Bernardick, E. (1986). Protection against chlamydia and gonorrhea by spermicides and the contraceptive sponge. Abstract presented at theSecond World Congress on Sexually Transmitted Diseases, Paris, France, June 1986Google Scholar
  12. 12.
    Alexander, W. J. (personal communication)Google Scholar
  13. 13.
    HicksD. R., MartinL. S., GetchellJ. P., HeathJ. L., FrancisD. P., McDougalJ. S., CurranJ. W. and VoellerB. (1985). Inactivation of HTLV-III/LAV infected cultures of normal human lymphocytes by N-9in vitro.Lancet,2, 1422–1423Google Scholar
  14. 14.
    StoneK. M., GrimesD. A. and MagderL. S. (1986). Primary prevention of sexually transmitted diseases.J. Am. Med. Assoc.,255(13), 1763–1766Google Scholar

Copyright information

© MTP Press Ltd. 1987

Authors and Affiliations

  • K. L. Berger
    • 1
  • K. Remington
    • 1
  1. 1.VLI CorporationIrvine

Personalised recommendations